HUMAN PAPILLOMA VIRUS
Clinical trials for HUMAN PAPILLOMA VIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMA VIRUS trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMA VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cash for clinics: new study aims to boost HPV vaccination in kids
⭐️ VACCINE ⭐️ OngoingThis study looks at whether giving clinics extra money and training can help doctors talk to parents about the HPV vaccine and get more children ages 9-12 vaccinated. Some clinics get only training, while others get training plus financial rewards and monthly progress reports. Th…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:54 UTC
-
Can less radiation after robotic surgery keep HPV throat cancer away?
Disease control OngoingThis study looks at whether giving lower doses of radiation to a smaller area after robotic surgery can still prevent HPV-related throat cancer from coming back. About 150 adults with early-stage cancer will receive this gentler treatment. The goal is to maintain cancer control w…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated May 17, 2026 00:59 UTC
-
New combo therapy aims to shrink throat tumors and cut radiation side effects
Disease control OngoingThis study tests whether adding experimental immune-boosting drugs (HB-201 and HB-202) to standard chemotherapy can shrink HPV16-positive throat tumors more effectively. The goal is to reduce the amount of radiation or chemotherapy needed afterward, potentially lowering side effe…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
New DIY HPV test could save thousands of lives
Diagnosis OngoingThis study checks if a new, low-cost HPV test (ScreenFire) that women can use themselves works as well as the standard test done by a doctor. About 9,100 women aged 30-59 will take part. If successful, it could make cervical cancer screening easier and more affordable in places w…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: The Cleveland Clinic • Aim: Diagnosis
Last updated May 14, 2026 12:03 UTC
-
Simple clinic training could boost HPV vaccination in preteens
Prevention OngoingThis study tests whether training primary care clinics to better use HPV vaccine standing orders can increase vaccination rates in children ages 9-12. Some clinics get communication training, others get extra tools. Researchers track vaccination data from about 27 clinics, but do…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Prevention
Last updated May 14, 2026 12:03 UTC
-
One shot may shield HIV-Positive women from HPV
Prevention OngoingThis study looks at whether a single dose of the HPV vaccine can protect women living with HIV from getting new HPV infections. The researchers are comparing immediate vaccination versus a delayed dose in 778 women who have already received an HPV vaccine. The goal is to see if o…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Prevention
Last updated May 12, 2026 13:40 UTC
-
One-Shot wonder? HPV vaccine trial could slash costs and save lives in africa
Prevention OngoingThis study tests whether a single dose of the HPV vaccine can protect Tanzanian girls aged 9-14 from cervical cancer just as well as the standard two or three doses. Around 900 girls will receive one, two, or three doses of either a bivalent or 9-valent HPV vaccine and be followe…
Matched conditions: HUMAN PAPILLOMA VIRUS
Phase: PHASE3 • Sponsor: London School of Hygiene and Tropical Medicine • Aim: Prevention
Last updated May 05, 2026 11:53 UTC
-
Can we predict throat cancer? 1500 volunteers join oral HPV watch
Knowledge-focused OngoingThis study screens 1500 adults for oral HPV infection and related antibodies to identify those at higher risk for HPV-related throat cancer. Researchers follow participants over time to see which infections persist and what factors (like mouth bacteria or immune response) play a …
Matched conditions: HUMAN PAPILLOMA VIRUS
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated May 17, 2026 00:59 UTC